Nasal Congestion
Top news of November: FDA oral phenylephrine removal, anaphylaxis, epinephrine, more
Healio has compiled November’s most read news in asthma and allergy.
Top in allergy/asthma: FDA proposal on oral phenylephrine; Medicaid barriers to care
Following an FDA review that found oral phenylephrine is ineffective in treating nasal congestion, the administration has proposed an order to remove the active ingredient from over-the-counter nasal decongestants.
Mobile app feature scores nasal congestion with voice recording
A new feature within the SONU app called SONUCheck allows individuals to check the openness of their nasal passages/congestion in real-time with a voice recording, according to a press release from SoundHealth Inc.
FDA proposes removing oral phenylephrine from nasal decongestants
The FDA has proposed an order for the removal of oral phenylephrine as an active ingredient from over-the-counter monograph drug products for relieving nasal congestion, according to an administration press release.
FDA approves dupilumab for adolescents with chronic rhinosinusitis with nasal polyps
Regeneron Pharmaceuticals Inc. and Sanofi announced the FDA approval of dupilumab for adolescents aged 12 to 17 years with chronic rhinosinusitis with nasal polyps.
Q&A: Wearable device uses acoustic resonance to treat nasal congestion
SoundHealth Inc. has launched SONU, the world’s first FDA-authorized, AI-enabled, over-the-counter, wearable medical device for the treatment of moderate to severe nasal congestion, according to a company press release.
Epinephrine nasal spray effective, tolerable with nasal congestion
Patients with nasal congestion experienced enhanced absorption of epinephrine when it was administered via nasal spray compared with intramuscular administration, according to a study published in Annals of Allergy, Asthma & Immunology.